NASDAQ:CVET
Delisted
Covetrus Inc. Stock News
$20.99
+0 (+0%)
At Close: Jan 27, 2023
Covetrus integra capacidades de telemedicina en su cartera de tecnologa global
06:21pm, Monday, 13'th Apr 2020
Covetrus (NASDAQ: CVET), líder global en tecnología y servicios para la salud animal, anunció hoy que está incorporando capacidades de teleconferencia
Samenvatting: Covetrus integreert de mogelijkheden van telegeneeskunde in zijn wereldwijde technologieportfolio
06:04pm, Monday, 13'th Apr 2020
Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, and prescription management.
Covetrus intgre des capacits de tlmdecine dans son portefeuille technologique global
05:59pm, Monday, 13'th Apr 2020
Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, and prescription management.
Covetrus integriert Telemedizinfunktionen in sein gesamtes, globales Technologieportfolio
04:06pm, Monday, 13'th Apr 2020
Covetrus (NASDAQ: CVET), ein weltweit führendes Unternehmen für Technologie und Dienstleistungen im Bereich Veterinärmedizin, gab heute bekannt, dass
Covetrus Integra Recursos de Telemedicina em seu Portflio Global de Tecnologia
03:22pm, Monday, 13'th Apr 2020
Covetrus (NASDAQ: CVET), líder mundial em serviços e tecnologia de saúde animal, anunciou hoje que está incorporando recursos seguros de teleconferênc
BRIEF-Covetrus Integrates Telemedicine Capabilities Across Its Technology Portfolio
12:10pm, Monday, 13'th Apr 2020
Covetrus Inc:
Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio
12:01pm, Monday, 13'th Apr 2020
New functionality allows veterinarians to leverage their existing Covetrus software and services to maintain continuity of care through COVID-19 and beyondPORTLAND, Maine — Covetrus (NASDAQ: …
Covetrus Integrates Telemedicine Capabilities Across Its Global Technology Portfolio
12:00pm, Monday, 13'th Apr 2020
Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, and prescription management.
Covetrus Inc (NASDAQ:CVET) Shares Sold by Bank of America Corp DE
08:46am, Monday, 13'th Apr 2020
Bank of America Corp DE cut its holdings in Covetrus Inc (NASDAQ:CVET) by 35.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
Man Group plc Reduces Position in Covetrus Inc (NASDAQ:CVET)
09:10am, Sunday, 12'th Apr 2020
Man Group plc lessened its holdings in shares of Covetrus Inc (NASDAQ:CVET) by 78.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commiss
Bank of New York Mellon Corp Acquires 82,674 Shares of Covetrus Inc (NASDAQ:CVET)
08:50am, Thursday, 09'th Apr 2020
Bank of New York Mellon Corp boosted its position in Covetrus Inc (NASDAQ:CVET) by 8.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Co
Covetrus Inc (NASDAQ:CVET) Shares Sold by Mason Street Advisors LLC
10:40am, Tuesday, 07'th Apr 2020
Mason Street Advisors LLC reduced its position in shares of Covetrus Inc (NASDAQ:CVET) by 33.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Excha
Connor Clark & Lunn Investment Management Ltd. Takes $1.08 Million Position in Covetrus Inc (NASDAQ:CVET)
08:44am, Sunday, 05'th Apr 2020
Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Covetrus Inc (NASDAQ:CVET) during the fourth quarter, according to its most recent Form 13F filing with the Securities
Covetrus Inc (NASDAQ:CVET) Holdings Decreased by Baird Financial Group Inc.
10:06am, Saturday, 04'th Apr 2020
Baird Financial Group Inc. lessened its stake in Covetrus Inc (NASDAQ:CVET) by 29.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The instituti
G.Research Comments on Covetrus Inc's FY2020 Earnings (NASDAQ:CVET)
07:48am, Saturday, 04'th Apr 2020
Covetrus Inc (NASDAQ:CVET) – Investment analysts at G.Research lowered their FY2020 earnings per share estimates for shares of Covetrus in a research report issued to clients and investors on Tuesda
